top of page


ORRxD is a preclinical drug discovery company specializing in: 


  • Virtual high throughput screening for hit discovery.

  • A pipeline of investigational new drugs.

  • Chemogenomic database of chemical compounds that bind to targets in the entire human proteome.


ORRxD has developed high expertise in structure-based High Performance Computing (HPC)-driven drug screening and assay development in concert with strong medicinal chemistry and biological validation to support a program in hit discovery, lead optimization and preclinical research up to Investigational New Drug (IND) discovery.

bottom of page